EQNTX
Price
$22.37
Change
-$0.26 (-1.15%)
Updated
Aug 1 closing price
Net Assets
644.97M
VIVAX
Price
$68.50
Change
-$0.59 (-0.85%)
Updated
Aug 1 closing price
Net Assets
195.18B
Interact to see
Advertisement

EQNTX vs VIVAX

Header iconEQNTX vs VIVAX Comparison
Open Charts EQNTX vs VIVAXBanner chart's image
MFS Equity Income R3
Price$22.37
Change-$0.26 (-1.15%)
VolumeN/A
Net Assets644.97M
Vanguard Value Index I
Price$68.50
Change-$0.59 (-0.85%)
VolumeN/A
Net Assets195.18B
EQNTX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EQNTX vs. VIVAX commentary
Aug 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNTX is a Buy and VIVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 195B vs. EQNTX (645M). VIVAX pays higher dividends than EQNTX: VIVAX (2.06) vs EQNTX (1.92). EQNTX was incepted earlier than VIVAX: EQNTX (13 years) vs VIVAX (33 years). EQNTX (0.95) is less costly to investors than VIVAX (0.17). EQNTX is a more actively managed with annual turnover of: 45.00 vs. VIVAX (9.00). EQNTX has a lower initial minimum investment than VIVAX: EQNTX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 5.69 vs. EQNTX (4.53). VIVAX return over 5 years is better than : 70.37 vs. EQNTX (59.65).
EQNTXVIVAXEQNTX / VIVAX
Total Expense Ratio0.890.17524%
Annual Report Gross Expense Ratio0.950.17559%
Fund Existence13 years33 years-
Gain YTD7.4853.740200%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets645M195B0%
Annual Yield % from dividends1.922.0693%
Returns for 1 year4.535.6980%
Returns for 3 years28.8428.41102%
Returns for 5 years59.6570.3785%
Returns for 10 years97.29110.2788%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLRX0.630.03
+5.12%
Salarius Pharmaceuticals Inc.
UFPT226.570.18
+0.08%
UFP Technologies
BNR5.67-0.09
-1.56%
Burning Rock Biotech Limited
KTOS56.71-1.99
-3.39%
Kratos Defense & Security Solutions
CIX22.26-1.04
-4.46%
Comp X International